Paul S. Scrivano
Paul S. Scrivano is global head of the firm’s mergers & acquisitions practice. The world’s leading companies turn to Paul for guidance in executing their most complex mergers and acquisitions transactions. Paul has extensive experience with a broad range of U.S. and cross-border transactions, including mergers, tender and exchange offers, stock and asset acquisitions, divestitures and joint ventures, and has advised on more than 100 public company deals. He is a veteran of numerous proxy contests and regularly advises corporate boards and committees in transactional and high-profile corporate governance matters and takeover defense strategies.
Paul is known for his broad skill set and experience steering multibillion-dollar deals in the technology, health care, pharmaceuticals, life sciences, consumer products, financial services, oil and gas, chemicals, energy, and telecommunications industries, among others. He also regularly advises private equity firms and investment banks in M&A transactions.
In 2017, he was named a Mergers & Acquisitions and Antitrust Trailblazer by The National Law Journal and named one of the “Top 100 Lawyers in California” by The Daily Journal. In 2015, he was named “California M&A Lawyer of the Year” at the ACQ Global Awards, and he received a “California Lawyer of the Year” award in 2014 from California Lawyer magazine. He has been named one of the “Top 100 Lawyers in California” by The Daily Journal in 2013, an “Americas Top 50 Lawyer” at the M&A Atlas Awards in 2014, a “Life Sciences MVP” by Law360 in 2012 and a “Super Lawyer” by Law & Politics Media Inc. for both the New York Metro area and Northern California.
Top legal publications and directories, including The Legal 500 U.S., consistently recognize Paul as a leading M&A practitioner. Paul has appeared on CNBC and Bloomberg TV to discuss M&A trends and developments and is frequently quoted in the press on M&A issues. His deal work has also been cited by leading news and industry publications.
- Representation of Gilead Sciences, Inc. in its pending exclusive option to acquire Pionyr Immunotherapeutics Inc., consisting of the acquisition by Gilead of a 49.9% equity interest in Pionyr for $275 million, an option for Gilead to acquire the remaining equity interests of Pionyr for $315 million, and up to $1.15 billion of potential future milestone payments to Pionyr equityholders
- Representation of Veeam Software Holding Limited, the leader in backup solutions that deliver cloud data management, in its $5 billion acquisition by Insight Partners
- Representation of Milacron Holdings Corp. in its $2 billion cash and stock merger with Hillenbrand, Inc.
- Representation of Wieland-Werke AG in its $1.2 billion acquisition of Global Brass and Copper Holdings, Inc.
- Representation of Qorvo, Inc., a leading semiconductor company, in:
- its acquisition of Decawave Limited, a pioneer in ultra-wideband (UWB) technology and provider of UWB solutions for mobile, automotive and IoT applications
- its acquisition of Custom MMIC Design Services, Inc., a leading supplier of high-performance GaAs and GaN monolithic microwave integrated circuits (MMICs) for defense, aerospace and commercial applications
- its acquisition of Active-Semi International, Inc., a private fabless supplier of programmable analog power solutions
- its collaboration transaction with Zomedica Pharmaceuticals involving the use of Qorvo’s bulk acoustic wave (BAW) technology
- Representation of Bain Capital in its $18 billion acquisition of Toshiba Memory Corporation from Toshiba Corporation, by way of a Bain Capital-led consortium including Apple, Seagate Technology, Kingston Technology, Hoya, Dell Technologies and SK Hynix
- Representation of The Hershey Company in its $420 million acquisition of the Pirate Brands business from B&G Foods, Inc.
- Representation of TPG in:
- its $737 million acquisition of Exactech, Inc., including the successful defense of the transaction against a competing bid made by another private equity fund
- its investment in the combined company created by the business combination of Amneal Pharmaceuticals and Impax Laboratories
- Representation of Mentor Graphics Corporation, a leading provider of electronic design automation (EDA) tools to the semiconductor industry, in its $4.5 billion acquisition by Siemens AG
- Representation of Regis Corporation in its sale and subsequent franchise of substantially all of its mall-based salons and its sale and subsequent franchise of its U.K. businesses
- Representation of Atlantic Media, Inc., a national media company that includes Quartz, National Journal Group, and Government Executive Media Group, in:
- the sale of Quartz, a global business news outlet, to Uzabase, a Japanese business intelligence and media company which is publicly traded on the Tokyo Stock Exchange, for cash and Uzabase stock
- the sale of a majority ownership stake in The Atlantic to Emerson Collective, which was founded and is run by Laurene Powell Jobs
- Representation of Celanese Corporation in its acquisition of the nylon compounding division of Nilit B.V.
Notable transactions in which Paul was involved prior to joining the firm include:
- Representation of Alaska Air Group, Inc. in its $4 billion acquisition of Virgin America Inc.
- Representation of BB&T Corporation in its $1.8 billion acquisition of National Penn Bancshares, Inc.
- Representation of Dealertrack Technologies, Inc. in:
- its $4 billion sale to Cox Automotive, Inc., by way of a cash tender offer followed by a second step merger
- its $1 billion cash and stock acquisition of Dealer Dot Com, Inc.
- Representation of Microsemi Corporation in its successful $2.5 billion “deal jump” for PMC-Sierra, Inc., resulting in the termination of PMC-Sierra’s existing merger agreement with Skyworks Solutions
- Representation of Bear Stearns Merchant Banking in its negotiated spinout and transition to independence from JPMorgan Chase during the 2008 Financial Crisis
- Representation of the Independent Directors of TRI Pointe Homes, Inc. in connection with TRI Pointe's $2.7 billion combination with the homebuilding division of Weyerhaeuser Company in a reverse Morris Trust transaction
- Representation of Honeywell International Inc. in its acquisition of Aviaso AG, an international aviation software company
- Representation of Samsung Electronics Co. Ltd. in its acquisition of NeuroLogica Corp., a leading designer, developer and manufacturer of computed tomography (CT) machines, including its world class portable CT scanners
- Co-author, “Director Oversight Duties Amidst COVID-19,” Harvard Law School Forum on Corporate Governance (May 8, 2020)
- Quoted, “Parties Prepare for Hostile Takeovers and Shareholder Activism,” Connecticut Financial News (CTFN) (April 1, 2020)
- Co-author, “The Risks of Not Strictly Complying with a “No Shop” Clause,” Ropes & Gray Alert (September 13, 2019)
- Co-author, “In Delaware, notices and deadlines matter,” International Law Office Corporate Finance/M&A Newsletter (July 3, 2019)
- Co-author, “Ropes & Gray Discusses How Notices and Deadlines Matter in Delaware,” Columbia University Law School “Blue Sky Blog” (March 27, 2019)
- Quoted, “Transformative Deals, Big PE Buys On Tap For 2019,” Law360 (January 1, 2019)
- Quoted, “Last Decade's Worth Of Megadeals Lifted Buyers' Stock Prices,” Law360 (November 29, 2018)
- Quoted, “Midterm Elections Could Fan Already Soaring M&A Optimism,” Law360 (October 26, 2018)
- Co-author, “Merging Faster: A New Structure for Merger of Equals or Other Large Stock-for-Stock Public Mergers,” Thomson Reuters’ Practical Law (September 24, 2018)
- Quoted, “M&A Leaders Not Sweating Fears of Rising Protectionism,” The American Lawyer (July 6, 2018)
- Co-author, “Updated Guidance (and Ground Rules) for Controlling Stockholder Deals,” Harvard Law School Forum on Corporate Governance and Financial Regulation (March 22, 2018)
- Co-author, “Company's unaffected market price is best evidence of fair value for appraisal valuations,” International Law Office Corporate Finance/M&A Newsletter (March 14, 2018)
- Quoted, “Industrials M&A in 2018 will reflect driving need for technological relevance,” Mergermarket (December 22, 2017)
- Quoted, “Deal-Makers Ready To Shake Off 2017’s Cloud Of Uncertainty,” Law360 (November 22, 2017)
- Quoted, “S/TMUS: Lengthy Regulatory Review with Potential Focus on Market Entry,” Event Driven/Reorg Research (October 23, 2017)
- Quoted, “The Deals, The Data, & The Drivers: TMT deal value dips at end of 3Q17 amidst increased protectionism; transition toward SaaS and data usage drives hardware consolidation,” Mergermarket (October 17, 2017)
- Quoted, “TRCO/SBGI: Delayed Closing Possible as Political ‘Noise’ Continues, Source Says,” Event Driven/Reorg Research (October 5, 2017)
- Co-author, “Forging Ahead with “Entire Fairness,” or Playing it Safer (Procedurally Speaking),” Harvard Law School Forum on Corporate Governance and Financial Regulation (September 22, 2017)
- Profiled, “Top 100 Lawyers in California,” The Daily Journal (September 20, 2017)
- Quoted, “Pitfalls of M&A,” Bank Director (August 11, 2017)
- Quoted, “Disney-Netflix split ‘not a welcomed development’,” CNBC (August 9, 2017)
- Quoted, “Potential Scripps, Discovery Merger Shows Seismic Media Shift,” Bloomberg BNA’s Antitrust on Bloomberg Law (July 28, 2017)
- Quoted, “Media Mergers About to Heat Up: Top M&A Lawyer,” The Deal (July 21, 2017)
- Quoted, “Activist Target: Why Gannett Could Take Another Stab at Tronc,” The Deal (July 21, 2017)
- Quoted, “Buyers Struggle To Stomach Valuation Gap Amid Uncertainty,” Law360 (July 6, 2017)
- Quoted, “Mentor Taps Longtime Atty For $4.5B 'Hell Or High Water' Sale,” Law360 (June 15, 2017)
- Quoted, “People (Dis)Pleaser: Job Cuts Core to Making Deals Pay Off,” Ignites (June 15, 2017)
- Quoted, “For What It’s Worth: Growth Questions Complicate M&A Valuation Talks,” Ignites (June 13, 2017)
- Quoted, “Shareholder activism prompts rise in carve-outs,” International Financial Law Review (May 3, 2017)
- Quoted, “Anthem-Cigna Deal Rejection Highlights Difficulty of Megamergers,” Bloomberg BNA (May 2, 2017)
- Quoted, “Delaware Rundown: What You Missed In Q1,” Law360 (April 11, 2017)
- Quoted, “Pharma Companies Turn to Deals Over Development, Top Lawyer Says,” Bloomberg BNA: Corporate Law & Accountability Report (April 4, 2017)
- TV Interview, “Deals Report: Semiconductor, Health Care M&A Outlook,” Bloomberg Markets (April 3, 2017)
- JD, magna cum laude, New York University School of Law, 1996; Order of the Coif
- BS, Cornell University, 1993